Lees Pharmaceutical Holdings Ltd.
Lee's Pharmaceutical Holdings markets proprietary, generic and licensed drugs—e.g., Livaracine and Yallaferon—to target high‑margin therapeutic segments in cardiovascular, oncology, rare diseases and women's health with growth potential in Asian markets.
Headquarters: China (CHN)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- Employees: 1,036
- HQ: Shatin
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.